Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes

被引：0

作者：

Lim, S. ^{[1
]}

Min, K. ^{[2
]}

Yu, J. -M. ^{[3
]}

Chamnan, P. ^{[4
]}

Kim, E. ^{[5
,13
]}

Yoon, K. -H. ^{[6
]}

Kwon, S. ^{[7
]}

Moon, M. ^{[8
]}

Lee, K. ^{[9
]}

Kim, D. -J. ^{[10
]}

Kim, M. ^{[11
]}

Wongtanate, M. ^{[12
]}

Kim, E. ^{[5
,13
]}

Kim, S. -H. ^{[13
]}

Lee, M. -K. ^{[14
]}

机构：

[1] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea

[2] Eulji Univ, Med Ctr, Seoul, South Korea

[3] Kangnam Sacred Heart Hosp, Seoul, South Korea

[4] Sunpasitthiprasong Hosp, Ubon Ratchathani, Thailand

[5] Ulsan Univ Hosp, Ulsan, South Korea

[6] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[7] Samsung Changwon Hosp, Chang Won, South Korea

[8] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea

[9] Ajou Univ Hosp, Suwon, South Korea

[10] Inje Univ, Ilsan Paik Hosp, Goyang, South Korea

[11] Inje Univ, Haeundae Paik Hosp, Busan, South Korea

[12] Nan Hosp, Nan, Thailand

[13] LG Life Sci, Seoul, South Korea

[14] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea

来源：

DIABETOLOGIA | 2015年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

109

引用

页码：S54 / S54

页数：1

共 50 条

[31] Efficacy and safety of gemigliptin in patients with type 2 diabetes
Yang, S. J.
Min, K. W.
Park, J. Y.
Kim, D. M.
Kim, Y. S.
Gupta, S. K.
Shivane, V. K.
Pitale, S.
Agarwal, P. K.
Sosale, A. R.
Dharmalingam, M.
Gandhi, P.
Mohan, V.
Kim, J. A.
Baik, S. H.
DIABETOLOGIA, 2012, 55 : S351 - S352
[32] Efficacy and Safety of Gemigliptin as Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on Metformin and Glimepiride
Han, Kyung Ah
Yu, Jae Myung
Jang, Hak Chul
Ahn, Kyu Jeung
Oh, Takkeun
Lee, Hyoung Woo
Lee, Daeho
Kim, Jae Taek
Park, Tae Sun
Nam, Joo Young
Chung, Choon Hee
Kim, Byung-Joon
Park, Seok Won
Kim, Sung-Ho
Park, Kyong Soo
DIABETES, 2016, 65 : A307 - A307
[33] Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride
Kim, S. -H.
Yu, J.
Jang, H.
Song, Y.
Ahn, K.
Oh, T.
Lee, H.
Lee, D.
Kim, J.
Park, T. -S.
Jeong, C. -H.
Kim, B. -J.
Han, K.
Park, K.
DIABETOLOGIA, 2016, 59 : S357 - S357
[34] Efficacy and safety of saxagliptin and metformin as initial combination therapy in patients with type 2 diabetes: a meta-analysis
Tan, Xue-Ying
Lu, Yang
Xuan, Li-Ping
Huang, Yong-Min
Hu, Jing-Bo
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 18816 - 18823
[35] Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride
Han, Kyung Ah
Yu, Jae Myung
Jang, Hak Chul
Song, Young Duk
Ahn, Kyu Jeung
Oh, Takkeun
Lee, Hyoung Woo
Lee, Daeho
Kim, Jae Taek
Jeong, Choon-hee
Kim, Byoung-joon
Park, Kyong Soo
DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S125 - S126
[36] Efficacy and Safety of Gemigliptin in Patients With Type 2 Diabetes
Yang, Sae Jeong
Min, Kyung Wan
Park, Joong Yeol
Kim, Do-Man
Kim, Yong Seong
Gupta, Sandeep Kumar
Shivane, Vyankatesh K.
Pitale, Shailesh
Agarwal, Pankaj Kumar
Sosale, Aravind R.
Dharmal-Ingam, Mala
Gandhi, Pramod
Mohan, V.
Mahesh, Uma
Kim, Jeong Ae
Kim, Pan Kyung
Baik, Sei Hyun
DIABETES, 2012, 61 : A594 - A594
[37] Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
Kubota, Akira
Maeda, Hajime
Kanamori, Akira
Matoba, Kiyokazu
Jin, Yasuyuki
Minagawa, Fuyuki
Obana, Mitsuo
Iemitsu, Kotaro
Ito, Shogo
Amamiya, Hikaru
Kaneshiro, Mizuki
Takai, Masahiko
Kaneshige, Hideaki
Hoshino, Kazuhiko
Ishikawa, Masashi
Minami, Nobuaki
Takuma, Tetsuro
Sasai, Nobuo
Aoyagi, Sachio
Kawata, Takehiro
Mokubo, Atsuko
Takeda, Hiroshi
Honda, Shin
Machimura, Hideo
Motomiya, Tetsuya
Waseda, Manabu
Naka, Yoshikazu
Tanaka, Yasushi
Terauchi, Yasuo
Matsuba, Ikuro
JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 503 - 509
[38] Efficacy and Safety of Saxagliptin plus Metformin as Initial Therapy in Patients with Type 2 Diabetes
Dou, Jingtao
Ma, Jianhua
Liu, Jun
Wang, Changjiang
Johnsson, Eva
Yao, Yolanda
Zhao, June
Pan, Changyu
DIABETES, 2017, 66 : A327 - A327
[39] Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naive Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
Yoon, Kun Ho
Shin, Jeong Ah
Kwon, Hyuk Sang
Lee, Seung Hwan
Min, Kyung Wan
Ahn, Yu Bae
Yoo, Soon Jib
Ahn, Kyu Jeung
Park, Sung Woo
Lee, Kwan Woo
Sung, Yeon Ah
Park, Tae Sun
Kim, Min Seon
Kim, Yong Ki
Nam, Moon Suk
Kim, Hye Soon
Park, Ie Byung
Park, Jong Suk
Woo, Jeong Taek
Son, Ho Young
DIABETES & METABOLISM JOURNAL, 2011, 35 (01) : 26 - 33
[40] Efficacy and safety of combination therapy with vildagliptin and metformin vs, metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis
Ding, Y.
Liu, Y.
Qu, Y.
Lin, M.
Dong, F.
Li, Y.
Cao, L.
Lin, S.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (08) : 2802 - 2817

← 1 2 3 4 5 →